Live Quote · OTCMDCLFHealthcare · Biotechnology

MedinCell S.A.

$34.39▲ 0.00%(+$0.00)

TickerSpark Score

48/100

▌ Weak

47

Valuation

20

Profitability

10

Growth

64

Health

100

Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MDCLF research report →

52-Week Range100% of range

Low

$6.98

Current

$34.39

High

$34.39

Company Overviewwww.medincell.com

About the company

MedinCell S. A. is a pharmaceutical company dedicated to creating a diverse array of medical treatments.

CEO: Christophe Douat
IPO: 2021
Employees: 131
HQ: Jacou, FR

Price Chart

+392.69% · this period

Valuation

Market Cap: $1.23B
P/E: -32.44
P/S: 54.31
P/B: -34.60
EV/EBITDA: -35.28
Div Yield: 0.00%

Profitability

Gross Margin: 0.00%
Op Margin: -130.65%
Net Margin: -160.30%
ROE: 133.14%
ROIC: -37.53%

Growth & Income

Revenue: $19.59M · -23.29%
Net Income: $-31,405,796 · -70.33%
EPS: $-0.88 · -39.68%
Op Income: $-25,598,830
FCF YoY: 0.00%

Performance & Tape

52W High: $34.39
52W Low: $6.98
50D MA: $13.01
200D MA: $8.48
Beta: 1.02
Avg Volume: 6

Get TickerSpark's AI analysis on MDCLF

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Coverage · MDCLF